Robert Nelsen - Aug 12, 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director, 10%+ Owner
Signature
By: Robert Nelsen, Managing Director, By: /s/ Mark McDonnell, as Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Aug 12, 2022
Transactions value $
$0
Form type
4
Date filed
8/16/2022, 09:05 PM
Previous filing
Jul 7, 2022
Next filing
Aug 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 -218K -2.79% $0.00 7.59M Aug 12, 2022 See footnote F1, F2
transaction VIR Common Stock Other $0 -282K -2.79% $0.00 9.83M Aug 12, 2022 See footnote F1, F3
transaction VIR Common Stock Other $0 +27.5K +9.31% $0.00 323K Aug 12, 2022 Direct F1, F4, F5
transaction VIR Common Stock Other $0 +1.68K +9.87% $0.00 18.7K Aug 12, 2022 See footnote F1, F4, F5
transaction VIR Common Stock Other $0 -218K -2.87% $0.00 7.37M Aug 15, 2022 See footnote F1, F2
transaction VIR Common Stock Other $0 -282K -2.87% $0.00 9.55M Aug 15, 2022 See footnote F1, F3
transaction VIR Common Stock Other $0 +27.5K +8.52% $0.00 350K Aug 15, 2022 Direct F1, F4, F5
transaction VIR Common Stock Other $0 +1.68K +8.98% $0.00 20.4K Aug 15, 2022 See footnote F1, F4, F5
transaction VIR Common Stock Other $0 -218K -2.96% $0.00 7.15M Aug 16, 2022 See footnote F1, F2
transaction VIR Common Stock Other $0 -282K -2.96% $0.00 9.27M Aug 16, 2022 See footnote F1, F3
transaction VIR Common Stock Other $0 +27.5K +7.85% $0.00 378K Aug 16, 2022 Direct F1, F4, F5
transaction VIR Common Stock Other $0 +1.68K +8.24% $0.00 22.1K Aug 16, 2022 See footnote F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of Common Stock held by a limited partnership to its partners for no consideration.
F2 The shares are held by ARCH Venture Fund IX, L.P. ("ARCH IX"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX, L.P., which is the sole general partner of ARCH IX, and shares voting and investment control with respect to shares held by ARCH IX. The Reporting Person may be deemed to beneficially own the shares held by ARCH IX, and the Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
F3 The shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), which is the sole general partner of ARCH Overage, and shares voting and investment control with respect to shares held by ARCH Overage. The Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
F4 Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
F5 Shares held by a trust for the benefit of family members of the Reporting Person.